10x Genomics ( (TXG) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
10x Genomics shares are climbing as investors react to strong momentum across the broader life science tools and diagnostics sector, which is boosting sentiment toward the company’s growth prospects. Reflecting this optimism, analysts at Canaccord have raised their price target on expectations of sustained expansion, while Barclays and Bank of America also lifted their targets, pointing to favorable market conditions. Not all Wall Street views are uniformly bullish, however: Citi has taken a more cautious stance and downgraded the stock to neutral, flagging potential risks despite the recent rally.
More about 10x Genomics
YTD Price Performance: 13.11%
Average Trading Volume: 2,797,266
Technical Sentiment Signal: Buy
Current Market Cap: $2.03B
For further insights into TXG stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.